Biotech etf IBB could see major upside in 2022 (Market Video Update)

After a weak year for biotech stocks both in absolute and relative terms, 2022 could set up to be a much better year. The IBB etf could set up bullishly for 2022.

Watch More:

Leave a Reply

Your email address will not be published. Required fields are marked *